- Home
- SANA
as 02-21-2025 4:00pm EST
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.
Upcoming Earnings Alert:
Get ready for potential market movements as Sana Biotechnology Inc. SANA prepares to release earnings report on 27 Feb 2025.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | SEATTLE |
| Market Cap: | 522.4M | IPO Year: | 2021 |
| Target Price: | $13.00 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.52 - $12.00 | Next Earning Date: | 02-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Sana Biotechnology Inc. (SANA)
Latest Sana Biotechnology Inc. News
SANA Breaking Stock News: Dive into SANA Ticker-Specific Updates for Smart Investing
Simply Wall St.
6 days ago
Metalpha Technology Holding And 2 Other US Penny Stocks To Monitor
Insider Monkey
25 days ago
Sana Biotechnology, Inc. (SANA): A Bull Case Theory
Insider Monkey
a month ago
Is Sana Biotechnology, Inc. (SANA) the Hottest Smid-Cap Stock So Far In 2025?
Zacks
a month ago
SANA Stock Surges 152% in a Week on Upbeat Initial Diabetes Study Data
GlobeNewswire
a month ago
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MT Newswires
a month ago
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT Newswires
a month ago
Top Midday Gainers
MT Newswires
a month ago
Sana Biotechnology Shares Surge After Diabetes Study Results, TD Cowen Upgrade
Compare SANA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SANA Sana Biotechnology Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.